Provided by Tiger Fintech (Singapore) Pte. Ltd.

OPKO Health

1.41
-0.0500-3.42%
Post-market: 1.470.0600+4.26%19:51 EDT
Volume:3.30M
Turnover:4.69M
Market Cap:946.89M
PE:-18.39
High:1.46
Open:1.44
Low:1.40
Close:1.46
Loading ...

OPKO Health Announces Progress in EBV Vaccine Study, Stock Gains

Zacks
·
08 Jan

OPKO Health Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
08 Jan

OPKO Health's ModeX Launches Phase 1 EBV Vaccine Candidate Trials With Merck

MT Newswires Live
·
08 Jan

BRIEF-OPKO Health’S Modex Therapeutics Announces Epstein-Barr Virus Vaccine Candidate Enters Phase I Clinical Study In Collaboration With Merck

Reuters
·
07 Jan

OPKO Health’s Modex Therapeutics Announces Epstein-Barr Virus Vaccine Candidate Enters Phase I Clinical Study in Collaboration With Merck

THOMSON REUTERS
·
07 Jan

Modex Therapeutics- Development Triggers Undisclosed Milestone Payment From Merck

THOMSON REUTERS
·
07 Jan

OPKO Health’s ModeX Therapeutics Announces Epstein-Barr Virus Vaccine Candidate Enters Phase I Clinical Study in Collaboration with Merck

GlobeNewswire
·
07 Jan

FACTBOX-Weight-loss drug developers line up to tap market worth $150 billion

Reuters
·
20 Dec 2024

Is OPKO Health (OPK) the Best NASDAQ Penny Stock to Buy Right Now?

Insider Monkey
·
11 Dec 2024

OPKO Health (NASDAQ:OPK) investors are sitting on a loss of 59% if they invested three years ago

Simply Wall St.
·
08 Dec 2024

OPKO Health to Participate in the Piper Sandler 36th Annual Healthcare Conference

GlobeNewswire
·
20 Nov 2024

NextPlat to Showcase OPKO Healthcare Products at the 2024 China International Natural Health & Nutrition Expo

PR Newswire
·
18 Nov 2024

NextPlat Reports $49.8 Million in Consolidated Revenue for the Nine Months Ended September 30, 2024, Representing a 136% Increase Over 2023 Results

THOMSON REUTERS
·
14 Nov 2024

Press Release: NextPlat Reports $49.8 Million in Consolidated Revenue for the Nine Months Ended September 30, 2024, Representing a 136% Increase Over 2023 Results

Dow Jones
·
14 Nov 2024

Phillip Frost Buys Handful Of Shares In OPKO Health

Simply Wall St.
·
11 Nov 2024

OPKO Health Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.
·
09 Nov 2024

OPKO Health Is Maintained at Outperform by Barrington Research

Dow Jones
·
09 Nov 2024

Entera Bio Reports Q3 2024 Financial Results and Provides Business Updates

THOMSON REUTERS
·
09 Nov 2024

OPK Stock Gains Following Q3 Earnings Beat, Gross Margin Contracts

Zacks
·
09 Nov 2024

Stock Track | OPKO Health Surges on Promising Pipeline and Strategic Progress

Stock Track
·
08 Nov 2024